IDEAS home Printed from https://ideas.repec.org/a/nas/journl/v118y2021pe2025786118.html
   My bibliography  Save this article

Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers

Author

Listed:
  • Jack H. Buckner

    (Graduate Group in Ecology, University of California, Davis, CA 95616)

  • Gerardo Chowell

    (Department of Population Health Sciences, School of Public Health, Georgia State University, Atlanta, GA 30303)

  • Michael R. Springborn

    (Department of Environmental Science and Policy, University of California, Davis, CA 95616)

Abstract

COVID-19 vaccines have been authorized in multiple countries, and more are under rapid development. Careful design of a vaccine prioritization strategy across sociodemographic groups is a crucial public policy challenge given that 1) vaccine supply will be constrained for the first several months of the vaccination campaign, 2) there are stark differences in transmission and severity of impacts from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across groups, and 3) SARS-CoV-2 differs markedly from previous pandemic viruses. We assess the optimal allocation of a limited vaccine supply in the United States across groups differentiated by age and essential worker status, which constrains opportunities for social distancing. We model transmission dynamics using a compartmental model parameterized to capture current understanding of the epidemiological characteristics of COVID-19, including key sources of group heterogeneity (susceptibility, severity, and contact rates). We investigate three alternative policy objectives (minimizing infections, years of life lost, or deaths) and model a dynamic strategy that evolves with the population epidemiological status. We find that this temporal flexibility contributes substantially to public health goals. Older essential workers are typically targeted first. However, depending on the objective, younger essential workers are prioritized to control spread or seniors to directly control mortality. When the objective is minimizing deaths, relative to an untargeted approach, prioritization averts deaths on a range between 20,000 (when nonpharmaceutical interventions are strong) and 300,000 (when these interventions are weak). We illustrate how optimal prioritization is sensitive to several factors, most notably, vaccine effectiveness and supply, rate of transmission, and the magnitude of initial infections.

Suggested Citation

  • Jack H. Buckner & Gerardo Chowell & Michael R. Springborn, 2021. "Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers," Proceedings of the National Academy of Sciences, Proceedings of the National Academy of Sciences, vol. 118(16), pages 2025786118-, April.
  • Handle: RePEc:nas:journl:v:118:y:2021:p:e2025786118
    as

    Download full text from publisher

    File URL: http://www.pnas.org/content/118/16/e2025786118.full
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Hazhir Rahmandad, 2022. "Behavioral responses to risk promote vaccinating high‐contact individuals first," System Dynamics Review, System Dynamics Society, vol. 38(3), pages 246-263, July.
    2. Bagues, Manuel & Dimitrova, Velichka, 2021. "The Psychological Gains from COVID-19 Vaccination: Who Benefits the Most?," IZA Discussion Papers 14826, Institute of Labor Economics (IZA).
    3. Aguilar-Canto, Fernando Javier & de León, Ugo Avila-Ponce & Avila-Vales, Eric, 2022. "Sensitivity theorems of a model of multiple imperfect vaccines for COVID-19," Chaos, Solitons & Fractals, Elsevier, vol. 156(C).
    4. Giagheddu, Marta & Papetti, Andrea, 2023. "The macroeconomics of age-varying epidemics," European Economic Review, Elsevier, vol. 151(C).
    5. Lin Chen & Fengli Xu & Zhenyu Han & Kun Tang & Pan Hui & James Evans & Yong Li, 2022. "Strategic COVID-19 vaccine distribution can simultaneously elevate social utility and equity," Nature Human Behaviour, Nature, vol. 6(11), pages 1503-1514, November.
    6. Wang, Jian & Jiang, Wenjing & Wu, Xinpei & Yang, Mengdie & Shao, Wei, 2023. "Role of vaccine in fighting the variants of COVID-19," Chaos, Solitons & Fractals, Elsevier, vol. 168(C).
    7. Rapeepong Suphanchaimat & Titiporn Tuangratananon & Nattadhanai Rajatanavin & Mathudara Phaiyarom & Warisara Jaruwanno & Sonvanee Uansri, 2021. "Prioritization of the Target Population for Coronavirus Disease 2019 (COVID-19) Vaccination Program in Thailand," IJERPH, MDPI, vol. 18(20), pages 1-17, October.
    8. Ghazal, Ikram & Rachadi, Abdeljalil & Ez-Zahraouy, Hamid, 2022. "Optimal allocation strategies for prioritized geographical vaccination for Covid-19," Physica A: Statistical Mechanics and its Applications, Elsevier, vol. 607(C).
    9. Ahmad Yaman Abdin & Francesco De Pretis & Jürgen Landes, 2023. "Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness," IJERPH, MDPI, vol. 20(3), pages 1-17, January.
    10. Dal Mas, Francesca & Massaro, Maurizio & Rippa, Pierluigi & Secundo, Giustina, 2023. "The challenges of digital transformation in healthcare: An interdisciplinary literature review, framework, and future research agenda," Technovation, Elsevier, vol. 123(C).
    11. Yiqing Su & Yanyan Li & Yanggui Liu, 2022. "Common Demand vs. Limited Supply—How to Serve the Global Fight against COVID-19 through Proper Supply of COVID-19 Vaccines," IJERPH, MDPI, vol. 19(3), pages 1-13, January.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nas:journl:v:118:y:2021:p:e2025786118. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Eric Cain (email available below). General contact details of provider: http://www.pnas.org/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.